Smart medication through combination of synthetic biology and cell microencapsulation

Metabolic Engineering

Volumn 14, Issue 3, 2012, Pages 252-260

  Ausländer, Simon ^a   Wieland, Markus ^a   Fussenegger, Martin ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Cell Implants; Encapsulation; Synthetic Biology; Synthetic Gene Networks

Indexed keywords

BIOLOGICAL NETWORKS; BIOMEDICAL APPLICATIONS; CELL MICROENCAPSULATION; CELL-BASED; EXTERNAL ENVIRONMENTS; IMMUNE SYSTEMS; IMPLANTABLE DRUG DELIVERY SYSTEMS; KEY ELEMENTS; LIVING CELL; MICROCAPSULES; MOLECULAR BASIS; SYNTHETIC BIOLOGY; SYNTHETIC GENE NETWORK;

CYTOLOGY; ENCAPSULATION; GENES; MEDICAL APPLICATIONS; PACKAGING;

CELLS;

2 PHENYLETHYLBUTYRATE; ALGINIC ACID; ANTIBIOTIC AGENT; ARGININE; BIOTIN; CELLULOSE SULFATE; DOXYCYCLINE; LUTEINIZING HORMONE; PHLORETIN; POLYLYSINE; POLYSULFONE; TETRACYCLINE; UNCLASSIFIED DRUG; URATE;

ARTICLE; BIOCOMPATIBILITY; BIOMEDICAL ENGINEERING; BIOMEDICINE; CELL ENCAPSULATION; CELL ENGINEERING; CELL PROTECTION; CELL TRANSPLANTATION; DRUG DELIVERY SYSTEM; GENE SWITCHING; HUMAN; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SYNTHETIC BIOLOGY; TRANSCRIPTION REGULATION;

ANIMALS; CAPSULES; CELL ENGINEERING; CELLS, IMMOBILIZED; DRUG DELIVERY SYSTEMS; HUMANS; SYNTHETIC BIOLOGY; TISSUE THERAPY;

EID: 84859771131     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2011.06.003     Document Type: Article

References (92)

1. Abalovich A.G., Bacque M.C., Grana D., Milei J. Pig pancreatic islet transplantation into spontaneously diabetic dogs. Transplant. Proc. 2009, 41:328-330.
2. Ascoli M., Fanelli F., Segaloff D.L. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. 2002, 23:141-174.
3. Bachoud-Levi A.C., Deglon N., Nguyen J.P., Bloch J., Bourdet C., Winkel L., Remy P., Goddard M., Lefaucheur J.P., Brugieres P., Baudic S., Cesaro P., Peschanski M., Aebischer P. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum. Gene Ther. 2000, 11:1723-1729.
4. Balch W.E., Morimoto R.I., Dillin A., Kelly J.W. Adapting proteostasis for disease intervention. Science 2008, 319:916-919.
5. Berens C., Hillen W. Gene regulation by tetracyclines-constraints of resistance regulation in bacteria shape TetR for application in eukaryotes. Eur. J. Biochem. 2003, 270:3109-3121.
6. Blancafort P., Segal D.J., Barbas C.F. Designing transcription factor architectures for drug discovery. Mol. Pharmacol. 2004, 66:1361-1371.
7. Blanco-Bose W.E., Schneider B.L., Aebischer P. Inducing tolerance to a soluble foreign antigen by encapsulated cell transplants. Mol. Ther. 2006, 13:447-456.
8. Bloch J., Bachoud-Levi A.C., Deglon N., Lefaucheur J.P., Winkel L., Palfi S., Nguyen J.P., Bourdet C., Gaura V., Remy P., Brugieres P., Boisse M.F., Baudic S., Cesaro P., Hantraye P., Aebischer P., Peschanski M. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Hum. Gene Ther. 2004, 15:968-975.
9. Calafiore R., Basta G., Luca G., Boselli C., Bufalari A., Bufalari A., Cassarani M.P., Giustozzi G.M., Brunetti P. Transplantation of pancreatic islets contained in minimal volume microcapsules in diabetic high mammalians. Bioartif. Organs II: Technol. Med. Mater. 1999, 875:219-232.
10. Cameron M.A., Sakhaee K. Uric acid nephrolithiasis. Urol. Clin. North Am. 2007, 34:335-346.
11. Catena R., Santos E., Orive G., Hernandez R.M., Pedraz J.L., Calvo A. Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system. J. Control Release 2010, 146:93-98.
12. Chang T.M. Semipermeable microcapsules. Science 1964, 146:524-525.
13. Chang T.M. Therapeutic applications of polymeric artificial cells. Nat. Rev. Drug Discovery 2005, 4:221-235.
14. Cruise G.M., Hegre O.D., Lamberti F.V., Hager S.R., Hill R., Scharp D.S., Hubbell J.A. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 1999, 8:293-306.
15. Culler S.J., Hoff K.G., Smolke C.D. Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins. Science 2010, 330:1251-1255.
16. Danino T., Mondragon-Palomino O., Tsimring L., Hasty J. A synchronized quorum of genetic clocks. Nature 2010, 463:326-330.
17. Deuschle U., Meyer W.K., Thiesen H.J. Tetracycline-reversible silencing of eukaryotic promoters. Mol. Cell Biol. 1995, 15:1907-1914.
18. Drury J.L., Mooney D.J. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003, 24:4337-4351.
19. Dubrot J., Portero A., Orive G., Hernandez R.M., Palazon A., Rouzaut A., Perez-Gracia J.L., Hervas-Stubbs S., Pedraz J.L., Melero I. Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells. Cancer Immunol. Immunother. 2010, 59:1621-1631.
20. Dusseault J., Tam S.K., Menard M., Polizu S., Jourdan G., Yahia L., Halle J.P. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J. Biomed. Mater. Res. A 2006, 76:243-251.
21. Duvivier-Kali V.F., Omer A., Parent R.J., O'Neil J.J., Weir G.C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 2001, 50:1698-1705.
22. Emerich D.F., Winn S.R., Hantraye P.M., Peschanski M., Chen E.Y., Chu Y.P., McDermott P., Baetge E.E., Kordower J.H. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 1997, 386:395-399.
23. Faustini M., Torre M.L., Stacchezzini S., Norberti R., Consiglio A.L., Porcelli F., Conte U., Munari E., Russo V., Vigo D. Boar spermatozoa encapsulated in barium alginate membranes: a microdensitometric evaluation of some enzymatic activities during storage at 18°C. Theriogenology 2004, 61:173-184.
24. Fluri D.A., Kemmer C., Daoud-El Baba M., Fussenegger M. A novel system for trigger-controlled drug release from polymer capsules. J Control Release 2008, 131:211-219.
25. Freundlieb S., Schirra-Muller C., Bujard H. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J. Gene Med. 1999, 1:4-12.
26. Fussenegger M., Morris R.P., Fux C., Rimann M., von Stockar B., Thompson C.J., Bailey J.E. Streptogramin-based gene regulation systems for mammalian cells. Nat. Biotechnol. 2000, 18:1203-1208.
27. Gitzinger M., Kemmer C., El-Baba M.D., Weber W., Fussenegger M. Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin. Proc. Natl. Acad. Sci. USA 2009, 106:10638-10643.
28. Gossen M., Bujard H. Tight control of gene-expression in mammalian-cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 1992, 89:5547-5551.
29. Govan J.R.W., Fyfe J.A.M., Jarman T.R. Isolation of alginate-producing mutants of Pseudomonas fluorescens, Pseudomonas putida and Pseudomonas mendocina. J. Gen. Microbiol. 1981, 125:217-220.
30. Hartenbach S., Daoud-El Baba M., Weber W., Fussenegger M. An engineered l-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice. Nucleic Acids Res. 2007, 35:e136.
31. Hasse C., Schrezenmeir J., Stinner B., Schark C., Wagner P.K., Neumann K., Rothmund M. Successful allotransplantation of microencapsulated parathyroids in rats. World J. Surg. 1994, 18:630-634.
32. Hasse C., Zielke A., Klock G., Schlosser A., Zimmermann U., Rothmund M. Isotransplantation of microencapsulated parathyroid tissue in rats. Exp. Clin. Endocrinol. Diabetes 1997, 105:53-56.
33. Hernandez R.M., Orive G., Murua A., Pedraz J.L. Microcapsules and microcarriers for in situ cell delivery. Adv. Drug Delivery Rev. 2010, 62:711-730.
34. Hernandez R.M., Orive G., Murua A., Pedraz J.L. Microcapsules and microcarriers for in situ cell delivery. Adv. Drug Deliv. Rev. 2010, 62:711-730.
35. Hunder N.N., Wallen H., Cao J., Hendricks D.W., Reilly J.Z., Rodmyre R., Jungbluth A., Gnjatic S., Thompson J.A., Yee C. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N. Engl. J. Med. 2008, 358:2698-2703.
36. Hunt N.C., Grover L.M. Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol. Lett. 2010, 32:733-742.
37. Husseinzadeh N. Status of tumor markers in epithelial ovarian cancer has there been any progress? A review. Gynecol. Oncol. 2011, 120:152-157.
38. Kawahara M. Neurotoxicity of beta-amyloid protein: oligomerization, channel formation and calcium dyshomeostasis. Curr. Pharm. Des. 2010, 16:2779-2789.
39. Kemmer, C., Fluri, D.A., Witschi, U., Passeraub, A., Gutzwiller, A., Fussenegger, M., 2010a. A designer network coordinating bovine artificial insemination by ovulation-triggered release of implanted sperms. J. Control Release 150, 23-29.
40. Kemmer C., Gitzinger M., Daoud-El Baba M., Djonov V., Stelling J., Fussenegger M. Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat. Biotechnol. 2010, 28. 355-U82.
41. Khalil A.S., Collins J.J. Synthetic biology: applications come of age. Nat. Rev. Genet. 2010, 11:367-379.
42. Kobayashi K., Yasuhara T., Agari T., Muraoka K., Kameda M., Ji Yuan W., Hayase H., Matsui T., Miyoshi Y., Shingo T., Date I. Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat. Brain Res. 2006, 1102:1-11.
43. Koo J., Chang T.M. Secretion of erythropoietin from microencapsulated rat kidney cells: preliminary results. Int. J. Artif. Organs 1993, 16:557-560.
44. Kramer B.P., Fischer C., Fussenegger M. BioLogic gates enable logical transcription control in mammalian cells. Biotechnol. Bioeng. 2004, 87:478-484.
45. Kutzing M.K., Firestein B.L. Altered uric acid levels and disease states. J. Pharmacol. Exp. Ther. 2008, 324:1-7.
46. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980, 210:908-910.
47. Ma Y.L., Feigin A., Dhawan V., Fukuda M., Shi Q.H., Greene P., Breeze R., Fahn S., Freed C., Eidelberg D. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann. Neurol. 2002, 52:628-634.
48. Melero I., Hervas-Stubbs S., Glennie M., Pardoll D.M., Chen L. Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer 2007, 7:95-106.
49. Morgan R.A., Dudley M.E., Wunderlich J.R., Hughes M.S., Yang J.C., Sherry R.M., Royal R.E., Topalian S.L., Kammula U.S., Restifo N.P., Zheng Z., Nahvi A., de Vries C.R., Rogers-Freezer L.J., Mavroukakis S.A., Rosenberg S.A. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006, 314:126-129.
50. Mullick A., Xu Y., Warren R., Koutroumanis M., Guilbault C., Broussau S., Malenfant F., Bourget L., Lamoureux L., Lo R., Caron A.W., Pilotte A., Massie B. The cumate gene-switch: a system for regulated expression in mammalian cells. BMC Biotechnol. 2006, 6:43.
51. Nordstrom J.L. Antiprogestin-controllable transgene regulation in vivo. Curr. Opin. Biotechnol. 2002, 13:453-458.
52. Okada N., Miyamoto H., Yoshioka T., Katsume A., Saito H., Yorozu K., Ueda O., Itoh N., Mizuguchi H., Nakagawa S., Ohsugi Y., Mayumi T. Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(l)lysine-alginate membrane. Biochim. Biophys. Acta-Mol. Basis Dis. 1997, 1360:53-63.
53. Orive G., De Castro M., Kong H.J., Hernandez R.M., Ponce S., Mooney D.J., Pedraz J.L. Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J. Control Release 2009, 135:203-210.
54. Orive G., Hernandez R.M., Gascon A.R., Calafiore R., Chang T.M., De Vos P., Hortelano G., Hunkeler D., Lacik I., Shapiro A.M., Pedraz J.L. Cell encapsulation: promise and progress. Nat. Med. 2003, 9:104-107.
55. Purnick P.E., Weiss R. The second wave of synthetic biology: from modules to systems. Nat. Rev. Mol. Cell Biol. 2009, 10:410-422.
56. Ramos J.L., Martinez-Bueno M., Molina-Henares A.J., Teran W., Watanabe K., Zhang X.D., Gallegos M.T., Brennan R., Tobes R. The TetR family of transcriptional repressors. Microbiol. Mol. Biol. Rev. 2005, 69:326-356.
57. Regot S., Macia J., Conde N., Furukawa K., Kjellen J., Peeters T., Hohmann S., de Nadal E., Posas F., Sole R. Distributed biological computation with multicellular engineered networks. Nature 2011, 469:207-211.
58. Rinaudo K., Bleris L., Maddamsetti R., Subramanian S., Weiss R., Benenson Y. A universal RNAi-based logic evaluator that operates in mammalian cells. Nat. Biotechnol. 2007, 25:795-801.
59. Rinaudo K., Bleris L., Maddamsetti R., Subramanian S., Weiss R., Benenson Y. A universal RNAi-based logic evaluator that operates in mammalian cells. Nat. Biotechnol. 2007, 25:795-801.
60. Roscilli G., Rinaudo C.D., Cimino M., Sporeno E., Lamartina S., Ciliberto G., Toniatti C. Long-term and tight control of gene expression in mouse skeletal muscle by a new hybrid human transcription factor. Mol. Ther. 2002, 6:653-663.
61. Rowley J.A., Mooney D.J. Alginate type and RGD density control myoblast phenotype. J. Biomed. Mater. Res. 2002, 60:217-223.
62. Saitoh Y., Taki T., Arita N., Ohnishi T., Hayakawa T. Cell therapy with encapsulated xenogeneic tumor cells secreting beta-endorphin for treatment of peripheral pain. Cell Transplant. 1995, 4(Suppl. 1):S13-S17.
63. Soon-Shiong P. Treatment of type I diabetes using encapsulated islets. Adv. Drug Delivery Rev. 1999, 35:259-270.
64. Soonshiong P., Feldman E., Nelson R., Heintz R., Yao Q., Yao Z.W., Zheng T.L., Merideth N., Skjakbraek G., Espevik T., Smidsrod O., Sandford P. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc. Natl. Acad. Sci. USA 1993, 90:5843-5847.
65. Soonshiong P., Heintz R.E., Merideth N., Yao Q.X., Yao Z.W., Zheng T.L., Murphy M., Moloney M.K., Schmehl M., Harris M., Mendez R., Mendez R., Sandford P.A. Insulin Independence in a type-1 diabetic patient after encapsulated islet transplantation. Lancet 1994, 343:950-951.
66. Sun Y.L., Ma X.J., Zhou D.B., Vacek I., Sun A.M. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Invest. 1996, 98:1417-1422.
67. Suzuki R., Okada N., Miyamoto H., Yoshioka T., Sakamoto K., Oka H., Tsutsumi Y., Nakagawa S., Miyazaki J., Mayumi T. Cytomedical therapy for insulinopenic diabetes using microencapsulated pancreatic beta cell lines. Life Sci. 2002, 71:1717-1729.
68. Tabor J.J., Levskaya A., Voigt C.A. Multichromatic control of gene expression in Escherichia coli. J. Mol. Biol. 2011, 405:315-324.
69. Tamsir A., Tabor J.J., Voigt C.A. Robust multicellular computing using genetically encoded NOR gates and chemical 'wires'. Nature 2011, 469:212-215.
70. Thorsen F., Read T.A., Lund-Johansen M., Tysnes B.B., Bjerkvig R. Alginate-encapsulated producer cells: a potential new approach for the treatment of malignant brain tumors. Cell Transplant. 2000, 9:773-783.
71. Tigges M., Denervaud N., Greber D., Stelling J., Fussenegger M. A synthetic low-frequency mammalian oscillator. Nucleic Acids Res. 2010, 38:2702-2711.
72. Tigges M., Marquez-Lago T.T., Stelling J., Fussenegger M. A tunable synthetic mammalian oscillator. Nature 2009, 457:309-312.
73. Toettcher J.E., Mock C., Batchelor E., Loewer A., Lahav G. A synthetic-natural hybrid oscillator in human cells. Proc. Natl. Acad. Sci. USA 2010, 107:17047-17052.
74. Vigo D., Faustini M., Villani S., Orsini F., Bucco M., Chlapanidas T., Conte U., Ellis K., Torre M.L. Semen controlled-release capsules allow a single artificial insemination in sows. Theriogenology 2009, 72:439-444.
75. Wang W., Liu X., Xie Y., Zhang H., Yu W., Xiong Y., Xie W., Ma X. Microencapsulation using natural polysaccharides for drug delivery and cell implantation. J. Mater. Chem. 2006, 16:3252-3267.
76. Weber W., Bacchus W., Daoud-El Baba M., Fussenegger M. Vitamin H-regulated transgene expression in mammalian cells. Nucleic Acids Res. 2007, 35:e116.
77. Weber W., Daoud-El Baba M., Fussenegger M. Synthetic ecosystems based on airborne inter- and intrakingdom communication. Proc. Natl. Acad. Sci. USA 2007, 104:10435-10440.
78. Weber W., Fussenegger M. Engineering of synthetic mammalian gene networks. Chem. Biol. 2009, 16:287-297.
79. Weber W., Fux C., Daoudel Baba M., Keller B., Weber C.C., Kramer B.P., Heinzen C., Aubel D., Bailey J.E., Fussenegger M. Macrolide-based transgene control in mammalian cells and mice. Nat. Biotechnol. 2002, 20:901-907.
80. Weber W., Lienhart C., Daoud-El Baba M., Fussenegger M. A biotin-triggered genetic switch in mammalian cells and mice. Metab. Eng. 2009, 11:117-124.
81. Weber W., Luzi S., Karlsson M., Sanchez-Bustamante C.D., Frey U., Hierlemann A., Fussenegger M. A synthetic mammalian electro-genetic transcription circuit. Nucleic Acids Res. 2009, 37:e33.
82. Weber W., Rimann M., Schafroth T., Witschi U., Fussenegger M. Design of high-throughput-compatible protocols for microencapsulation, cryopreservation and release of bovine spermatozoa. J. Biotechnol. 2006, 123:155-163.
83. Weber W., Schoenmakers R., Keller B., Gitzinger M., Grau T., Daoud-El Baba M., Sander P., Fussenegger M. A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc. Natl. Acad. Sci. USA 2008, 105:9994-9998.
84. Wieland M., Fussenegger M. Ligand-dependent regulatory RNA parts for synthetic biology in eukaryotes. Curr. Opin. Biotechnol. 2010, 21:760-765.
85. Win M.N., Smolke C.D. Higher-order cellular information processing with synthetic RNA devices. Science 2008, 322:456-460.
86. Wong H., Chang T.M. Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int. J. Artif. Organs 1986, 9:335-336.
87. Wong H., Chang T.M. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. Biomater. Artif. Cells Artif. Organs 1988, 16:731-739.
88. Wu X.W., Wakamiya M., Vaishnav S., Geske R., Montgomery C., Jones P., Bradley A., Caskey C.T. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc. Natl. Acad. Sci. USA 1994, 91:742-746.
89. Xue H., Lu B., Lai M. The cancer secretome: a reservoir of biomarkers. J. Transl. Med. 2008, 6:52.
90. You L.C., Cox R.S., Weiss R., Arnold F.H. Programmed population control by cell-cell communication and regulated killing. Nature 2004, 428:868-871.
91. Zhang F., Cong L., Lodato S., Kosuri S., Church G.M., Arlotta P. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat. Biotechnol. 2011, 29:149-153.
92. Zhang H., Zhu S.J., Wang W., Wei Y.J., Hu S.S. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther. 2008, 15:40-48.